TrialMultiple sclerosis (Houndmills, Basingstoke, England)2023

Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension.

Stephen L Hauser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.